pharma
PHARMA
Danish drugmaker Novo Nordisk profits jump in diabetes scourge
Pharmaceutical company Novo Nordisk, the world's leading insulin provider, on Wednesday reported a six percent jump in net profit in the first quarter, as the global onslaught of diabetes continued to grow.